Tag: Regeneron Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Regeneron Pharmaceuticals

Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In ...

Added to Collection on: 2024-12-17 18:10:35

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Macular edema
Regeneron Pharmaceuticals
Central retinal vein occlusion
Bayer
Diabetic retinopathy
Macular degeneration
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals - GlobalData

Added to Collection on: 2024-12-24 16:39:16

Tags for this article:

Immunology
Biotechnology
Immune system
Glycoproteins
Pharmacy
Antibody
Polyclonal antibodies
Biopharmaceutical
Regeneron Pharmaceuticals
Pharmaceutical industry
Monoclonal antibody

Click the tags to see associated articles and topics

View Article Details
Regeneron Pharmaceuticals Inc (REGN) Announces Top 40 Finalists - GuruFocus

Added to Collection on: 2025-01-23 18:13:27

Tags for this article:

society for science & the public
Regeneron Pharmaceuticals
ISTS
Society for Science
Regeneron Science Talent Search
Science, technology, engineering, and mathematics
George Yancopoulos
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Personal Jurisdiction Over Foreign Companies that File an ANDA or aBLA in the U.S. - JD Supra

Added to Collection on: 2025-01-31 19:57:43

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Aflibercept
Biosimilar
Monoclonal antibodies
Samsung
Injunction
United States

Click the tags to see associated articles and topics

View Article Details
Regeneron Misses on Eylea, Dupixent Sales; Issues First-Ever Dividends - BioSpace

Added to Collection on: 2025-02-04 15:25:53

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Leonard Schleifer
Aflibercept
Pharmaceutical industry
Blockbuster
Macular edema
Tuesday Morning
Dupilumab
Eylea

Click the tags to see associated articles and topics

View Article Details
RFK Jr. Advances, Q4 Earnings Roll Out and a Non-Opioid Pain Drug Hits the Market

Added to Collection on: 2025-02-05 17:16:37

Tags for this article:

Research and development in the United States
Eli Lilly and Company
Novo Nordisk
Pfizer
Semaglutide
Regeneron Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
REGENERON PHARMACEUTICALS, INC. SEC 10-K Report - TradingView

Added to Collection on: 2025-02-05 16:20:34

Tags for this article:

Regeneron Pharmaceuticals
Sanofi
Biosimilar
Pharmaceuticals policy
Bayer
Aflibercept
Pharmaceutical industry
Healthcare in the United States
Eylea
United States

Click the tags to see associated articles and topics

View Article Details
The Spark Of Change In Healthcare's 2024 Investment Ecosystem - Life Science Leader

Added to Collection on: 2025-02-06 19:24:47

Tags for this article:

Corporate finance
Private equity
Equity securities
Special-purpose acquisition company
Catalent
Roche
Venture capital
Novartis
Genmab
Bristol-Myers Squibb
Regeneron Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Regeneron Pharmaceuticals Inc (REGN) Announces Positive Phase 3 - GuruFocus

Added to Collection on: 2025-02-08 23:20:43

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Macular edema
Central retinal vein occlusion
Regeneron Pharmaceuticals
Anti-VEGF
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
FDA to review Sanofi and Regeneron's Dupixent sBLA for bullous pemphigoid

Added to Collection on: 2025-02-18 17:20:37

Tags for this article:

Sanofi
Autoimmune diseases
CAC 40
Dupilumab
Regeneron Pharmaceuticals
Immunology
Type 2 inflammation
Pemphigoid
Atopic dermatitis
Aflibercept
Bullous pemphigoid
Interleukin 13
Regeneron

Click the tags to see associated articles and topics

View Article Details